“We are pleased to have been selected as a finalist for this year’s TripleTree iAwards,” said Cary Breese, CEO, NowRx. “The awards program provides strong validation of this historic opportunity to reconceive the $400 billion pharmacy industry, an industry that hasn’t been modernized for decades and is at the very core of the U.S. healthcare system.”
NowRx, an on-demand pharmacy solution of sorts, just closed a $7 million Series A round via the SeedInvest crowdfunding platform. The company had previously raised a $3 million seed round.
Launched in 2016, NowRx is a full-fledged on-demand pharmacy solution. Though, it’s technically more of an on-demand prescription medication startup that functions using what it describes as a virtual pharmacy. Since its launch, NowRx has delivered more than 50,000 prescriptions from 1,900 doctors. With 8,500 customers, NowRx does about $5 million a year in annual revenue.
A mobile healthcare company whose app helps consumers expedite prescription refills and delivery has raised $2 million in new funding. NowRx, which calls itself an on-demand pharmacy and is based in Mountain View, Calif., will use the money to further automate its prescription fulfillment program and develop more analytics for drug utilization review, a process for reviewing, prescribing, dispensing and using medication.